These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21040668)

  • 1. [Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir].
    Hansen PB; Al-Farra G
    Ugeskr Laeger; 2010 Oct; 172(42):2907-8. PubMed ID: 21040668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
    Heath JA; Broxson EH; Dole MG; Filippa DA; George D; Lyden D; Dunkel IJ
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):160-3. PubMed ID: 11998794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary central nervous system posttransplant lymphoproliferative disease: An uncommon diagnostic dilemma.
    Degen D; Kanellis J; Hughes P; Barit D; Ierino F
    Nephrology (Carlton); 2016 Jun; 21(6):528. PubMed ID: 27188412
    [No Abstract]   [Full Text] [Related]  

  • 4. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus.
    Tsang HH; Trendell-Smith NJ; Wu AK; Mok MY
    Lupus; 2010 Mar; 19(3):330-3. PubMed ID: 19897521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system.
    van de Glind G; de Graaf S; Klein C; Cornelissen M; Maecker B; Loeffen J
    Pediatr Blood Cancer; 2008 Apr; 50(4):886-8. PubMed ID: 17668865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma.
    Ohguro N; Hashida N; Tano Y
    Arch Ophthalmol; 2008 Jul; 126(7):1002-3. PubMed ID: 18625954
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (Rituximab) for a post transplantation Epstein Barr virus-linked lymphoma.
    Sirvent-Von Bueltzingsloewen A; Sirvent N; Morand P; Cassuto JP
    Med Pediatr Oncol; 2003 Jun; 40(6):408-9. PubMed ID: 12692818
    [No Abstract]   [Full Text] [Related]  

  • 8. [Epstein-Barr virus-associated posttransplant lymphoproliferative disease after renal transplantation].
    Matsubara E; Yakushijin Y; Nomura T; Iwamasa K; Narumi H; Sakai I; Yasukawa M; Fujita S; Hato T; Ohshima K; Uno M
    Rinsho Ketsueki; 2002 Oct; 43(10):949-53. PubMed ID: 12462032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial.
    Blaes AH; Peterson BA; Bartlett N; Dunn DL; Morrison VA
    Cancer; 2005 Oct; 104(8):1661-7. PubMed ID: 16149091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of malignant lymphoma after renal transplantation].
    Oyama H; Yamao K; Sugiyama T; Matsuura O; Murakami S; Ikeda K; Inoue S
    No Shinkei Geka; 1997 Jul; 25(7):655-60. PubMed ID: 9218261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive posttransplant lymphoproliferative disease in a renal transplant patient treated with alemtuzumab.
    Muzaffar M; Taj A; Ratnam S
    Am J Ther; 2010; 17(6):e230-3. PubMed ID: 19918163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quiz page. Posttransplantation lymphoproliferative disorder (PTLD) involving the brain and the allograft.
    Tang S; Lai KN
    Am J Kidney Dis; 2005 Apr; 45(4):A55, e61-2. PubMed ID: 15806458
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-transplant lymphoproliferative disorder presenting as multiple myeloma.
    Ninan MJ; Datta YH
    Am J Hematol; 2010 Aug; 85(8):635-7. PubMed ID: 20578201
    [No Abstract]   [Full Text] [Related]  

  • 14. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
    Azarpira N; Torabineghad S; Rakei M
    Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of lytic Epstein-Barr virus (EBV) infection by synergistic action of rituximab and dexamethasone renders EBV-positive lymphoma cells more susceptible to ganciclovir cytotoxicity in vitro and in vivo.
    Daibata M; Bandobashi K; Kuroda M; Imai S; Miyoshi I; Taguchi H
    J Virol; 2005 May; 79(9):5875-9. PubMed ID: 15827204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case records of the Massachusetts General Hospital. Case 8-2006. A 71-year-old woman with Crohn's disease and altered mental status.
    Podolsky DK; Gonzalez RG; Hasserjian RP
    N Engl J Med; 2006 Mar; 354(11):1178-84. PubMed ID: 16540619
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
    Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
    Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of post-transplant lymphoproliferative disease and visceral leishmaniasis after kidney transplantation].
    Bacha MM; Abderrahim E; Ounissi M; Chaouech D; Cherif M; Turki S; Rajhi H; Znaidi N; Bahloul A; Trabelsi S; Khaled S; Ben Abdallah T; Ben Maïz H; Kheder A
    Nephrol Ther; 2011 Nov; 7(6):488-93. PubMed ID: 21376690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of central nervous system PTLD with rituximab and cranial radiotherapy.
    Said-Conti V; Amrolia PJ; Gaze MN; Stoneham S; Sebire N; Shroff R; Marks SD
    Pediatr Nephrol; 2013 Oct; 28(10):2053-6. PubMed ID: 23743853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus encephalitis in a renal allograft recipient diagnosed by polymerase chain reaction on cerebrospinal fluid and successfully treated with ganciclovir.
    MacGinley R; Bartley PB; Sloots T; Johnson DW
    Nephrol Dial Transplant; 2001 Jan; 16(1):197-8. PubMed ID: 11209035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.